Literature DB >> 15956422

Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan.

Frédéric Dalle1, Pierre Emmanuel Charles, Karine Blanc, Denis Caillot, Pascal Chavanet, Françoise Dromer, Alain Bonnin.   

Abstract

We report a case of cryptococcosis in which a serum enzyme-linked immunosorbent assay (ELISA) for Aspergillus galactomannan was positive, with no evidence of aspergillosis. Soluble antigens from 19 Cryptococcus neoformans strains and purified carbohydrates of C. neoformans capsule were thus assayed in the Aspergillus galactomannan ELISA. Antigens from all C. neoformans strains, and purified galactoxylomannan, gave a positive reaction, suggesting that C. neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15956422      PMCID： PMC1151935          DOI： 10.1128/JCM.43.6.2929-2931.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Transient aspergillus antigenaemia: think of milk.

Authors:  Jean-Pierre Gangneux; Dominique Lavarde; Stéphane Bretagne; Claude Guiguen; Virginie Gandemer
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.

Authors:  R Kappe; A Schulze-Berge
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.

Authors:  E Reiss; R Cherniak; R Eby; L Kaufman
Journal:  Diagn Immunol       Date:  1984

4.  False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.

Authors:  Daniele Mattei; Davide Rapezzi; Nicola Mordini; Federica Cuda; Cristiana Lo Nigro; Maura Musso; Aldo Arnelli; Sebastiano Cagnassi; Andrea Gallamini
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus.

Authors:  J P Latgé; H Kobayashi; J P Debeaupuis; M Diaquin; J Sarfati; J M Wieruszeski; E Parra; J P Bouchara; B Fournet
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.

Authors:  Kieren A Marr; S Arunmozhi Balajee; Lisa McLaughlin; Marc Tabouret; Christopher Bentsen; Thomas J Walsh
Journal:  J Infect Dis       Date:  2004-07-01       Impact factor: 5.226

Review 8.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.

Authors:  R Cherniak; L C Morris; B C Anderson; S A Meyer
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

Authors:  Claudio Viscoli; Marco Machetti; Paola Cappellano; Barbara Bucci; Paolo Bruzzi; Maria Teresa Van Lint; Andrea Bacigalupo
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079
View more
  27 in total

1.  Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.

Authors:  Rafael Borrás; Patricia Roselló; Marifina Chilet; Dayana Bravo; Juan García de Lomas; David Navarro
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

2.  Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.

Authors:  Wei Hao; Yu-Xian Pan; Yan-Qing Ding; Sha Xiao; Kai Yin; Ya-Di Wang; Li-Wen Qiu; Qing-Lin Zhang; Patrick C Y Woo; Susanna K P Lau; Kwok-Yung Yuen; Xiao-Yan Che
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

3.  Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay.

Authors:  Magdia De Jesus; Emily Hackett; Michelle Durkin; Patricia Connolly; Arturo Casadevall; Ruta Petraitiene; Thomas J Walsh; L Joseph Wheat
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

4.  Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis.

Authors:  S Ranque; R Pelletier; A Michel-Nguyen; F Dromer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

5.  Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.

Authors:  Melissa O Xavier; Alessandro C Pasqualotto; Isabel Cristina E Cardoso; Luiz Carlos Severo
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

6.  Galactomannan testing for early diagnosis of Exserohilum rostratum infection.

Authors:  Maya Korem; Itzhack Polacheck; Ayelet Michael-Gayego; Jacob Strahilevitz
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

7.  Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.

Authors:  D Van den Bossche; A De Bel; M Hendrickx; A De Becker; R Jacobs; A Naessens; D Piérard
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

8.  Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.

Authors:  E Fréalle; K Decrucq; F Botterel; B Bouchindhomme; D Camus; E Dei-Cas; J M Costa; I Yakoub-Agha; S Bretagne; L Delhaes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-02       Impact factor: 3.267

9.  Galactomannan Assay and Invasive Pulmonary Aspergillosis - Comparison of the Test Performance at an in-house and the Kit Cut-off.

Authors:  Jayanthi Savio; Nikhilesh Ravikumar Menon; Arun Ramachandran Sudharma; Vinutha Jairaj; Joshila Mathew
Journal:  J Clin Diagn Res       Date:  2016-08-01

10.  Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.

Authors:  Yu-Tsung Huang; Chien-Ching Hung; Chun-Hsing Liao; Hsin-Yun Sun; Shan-Chwen Chang; Yee-Chun Chen
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.